$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Novel topical formulations of Terbinafine-HCl for treatment of onychomycosis

European journal of pharmaceutical sciences, v.48 no.4/5, 2013년, pp.628 - 636  

Tanriverdi, S.T. ,  Ozer, O.

Abstract AI-Helper 아이콘AI-Helper

Terbinafine hydrochloride (TBF-HCl) is an active substance that is using for treatment of onychomycosis. Onychomycosis is a fungal infection which is the most common disease of nail plate. The nail plate is a barrier which prevents effective topical treatment of ungual disorders. In this study, TBF-...

주제어

참고문헌 (70)

  1. Semin. Dermatol. Achten 10 54 1991 Nails in light and electron microscopy 

  2. Drug Deliv. Ainbinder 12 297 2005 10.1080/10717540500176910 Testosterone ethosomes for enhanced transdemal delivery 

  3. Am. J. Med. Sci. Ajit 325 292 2003 10.1097/00000441-200305000-00008 Terbinafine-associated hepatotoxicity 

  4. Pharm. Res. Alberti 18 1472 2001 10.1023/A:1012217209228 Assessment and prediction of the cutaneous bioavailability of topical terbinafine, in vivo, in man 

  5. Int. J. Pharm. Alberti 219 11 2001 10.1016/S0378-5173(01)00616-0 Effevt of ethanol and isopropyl myristate on the availability of topica terbinafine in human stratum corneum, in vivo 

  6. J. Controlled Release Alberti 71 319 2001 10.1016/S0168-3659(01)00244-9 In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum 

  7. J. Mol. Biol. Bangham 13 238 1965 10.1016/S0022-2836(65)80093-6 Diffusion of univalent ions across the lamellae of swollen phospholipids 

  8. Int. J. Pharm. Betz 296 1-2 44 2005 10.1016/j.ijpharm.2005.02.032 In vivo comparison of various liposome formulations for cosmetic application 

  9. AJBPR Bharadwaj 4 1 2011 Formulation of acyclovir loaded liposome based gel 

  10. Int. J. Pharm. Bogataj 177 211 1999 10.1016/S0378-5173(98)00341-X Influence of phsicochemical and biological parameter on drug release from microspheres adhered on vesical and intestinal mucosa 

  11. Int. J. Pharm. Brown 370 61 2009 10.1016/j.ijpharm.2008.11.009 Overcoming the nail barrier: a systematic investigation of ungual chemical penetration enhancement 

  12. Eur. J. Gastroenterol. Hepatol. Chambers 13 1115 2001 10.1097/00042737-200109000-00021 Terbinafine-induced hepatic dysfunction 

  13. US Dermatol. Rev. Dahdah 1 1 2006 10.1586/17469872.1.1.1 Onychomycosis-an overview 

  14. Am. J. Clin. Dermatol. Darkes 4 1 39 2003 10.2165/00128071-200304010-00005 Terbinafine: a review of its use in onychomycosis in adults 

  15. Int. J. Pharm. Dash 190 21 1999 10.1016/S0378-5173(99)00221-5 Development of a rectal nicotine delivery system for the treatment of ulcerative colitis 

  16. Clin. Pharmacokinet. Debruyne 40 441 2001 10.2165/00003088-200140060-00005 Pharmacokinetics of antifungal agents in onychomycoses 

  17. Int. Wound J. Degim 8 343 2011 10.1111/j.1742-481X.2011.00795.x Evaluation of chitosan gel containing liposome-loaded epidermal growth factor on burn wound healing 

  18. Br. J. Dermatol. Dykes 123 481 1990 10.1111/j.1365-2133.1990.tb01453.x Determination of terbinafine in nail samples during systemic treatment for onychomycoses 

  19. Pharmacoeconomics. Apr. Einarson 9 4 307 1996 10.2165/00019053-199609040-00004 Clinical and economic factors in the treatment of onychomycosis 

  20. Clin Microbiol Rev. Elewski 11 3 415 1998 10.1128/CMR.11.3.415 Onychomycosis: pathogenesis, diagnosis, and management 

  21. Int. J. Pharm. Fang 356 144 2008 10.1016/j.ijpharm.2008.01.020 Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy 

  22. J. Exp. Biol. Farren 207 735 2004 10.1242/jeb.00814 The fracture properties and mechanical design of human fingernails 

  23. J. Dermatol. Treat. Finlay 1 51 1990 10.3109/09546639009089035 Nail matrix kinetics of oral terbinafi in onychomycosis and normal nails 

  24. Int. J. Pharm. Foco 291 21 2005 10.1016/j.ijpharm.2004.07.039 Investigation of liposomes as carriers of sodium ascorbyl phosphate for cutaneous photoprotection 

  25. J. Drug Target. Fresta 4 95 1996 10.3109/10611869609046267 Application of liposomes as potential cutaneous drug delivery systems: in vitro and in vivo investigation with radioactivity labelled vesicles 

  26. Tetrahedron Fuglseth 65 9807 2009 10.1016/j.tet.2009.09.067 Chiral derivatives of butenafine and terbinafine: synthesis and antifungal activity 

  27. Cell. Mol. Biol. Garson 46 6 1025 2000 Histological structure of human nails as studied by synchrotron X-ray microdiffraction 

  28. J. Am. Acad. Dermatol. Ghannoum 43 641 2000 10.1067/mjd.2000.107754 A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns 

  29. Eur. J. Pharm. Sci. Gunt 32 254 2007 10.1016/j.ejps.2007.07.009 Effect of hydration on the permeation of ketoconazole through human nail plate in vitro 

  30. J. Am. Acad. Dermatol. Gupta 37 979 1997 10.1016/S0190-9622(97)70076-8 Terbinafine: an update 

  31. Eur. J. Pharm. Sci. Hagerstrom 9 301 2001 10.1016/S0928-0987(99)00070-6 Evaluation of mucoadhesion for two polyelectrolyte gels in simulated physiological conditions using a rheological method 

  32. Drug Dev. Ind. Pharm. Hui 2012 10.3109/03639045.2012.704041 Onychopharmacokinetics of terbinafine hydrochloride penetration from a novel topical formulation into the human nail in vitro 

  33. Cosmet. Toiletries Imbert 110 32 1995 Topical delivery with liposomes 

  34. J. Appl. Polym. Sci. Jones 61 2229 1996 10.1002/(SICI)1097-4628(19960919)61:12<2229::AID-APP24>3.0.CO;2-0 Texture profile analysis of bioadhesive polymeric semisolids: mechanical characterization and investigation of interactions between formulation components 

  35. Int. J. Pharm. Jones 151 223 1997 10.1016/S0378-5173(97)04904-1 Textural analysis and flow rheometry of novel, bioadhesive antimicrobial oral gels 

  36. Pharm. Res. Jones 14 450 1997 10.1023/A:1012091231023 Textural, viscoelastic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers 

  37. Pharm. Res. Khengar 24 2207 2007 10.1007/s11095-007-9368-3 Nail swelling as a pre-formulation screen for the selection and optimisation of ungual penetration enhancers 

  38. Pharm. Res. Kim 18 10 1468 2001 10.1023/A:1012265125158 A method to measure the amount of drug penetrated across the nail plate 

  39. J. Pharm. Pharmacol. Kobayashi 51 271 1999 10.1211/0022357991772448 Drug permeation through the three layers of the human nail plate 

  40. Eur. J. Pharm. Sci. Kobayashi 21 471 2004 10.1016/j.ejps.2003.11.008 In vitro permeation of several drugs through the human nail plate: relationship between physicochemical properties and nail permeability of drugs 

  41. Int. J. Pharm. Lopez-Pinto 298 1 2005 10.1016/j.ijpharm.2005.02.021 Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes 

  42. J. Am. Acad. Dermatol. Lubeck 38 64 1998 10.1016/S0190-9622(98)70487-6 Measuring health-related quality of life in onychomycosis 

  43. Int. J. Pharm. Maestrelli 298 55 2005 10.1016/j.ijpharm.2005.03.033 Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery 

  44. J. Pharm. Pharmacol. Mezei 34 473 1982 10.1111/j.2042-7158.1982.tb04767.x Liposomes - a selective drug delivery system for the topical route of administration: gel dosage form 

  45. Br. J. Dermatol. Monti 162 311 2010 10.1111/j.1365-2133.2009.09504.x Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity 

  46. Eur. J. Pharm. Biopharm. Mura 67 86 2007 10.1016/j.ejpb.2007.01.020 Development, characterization and in vivo evaluation of benzocaine-loaded liposomes 

  47. Int. J. Pharm. Murdan 236 1 2002 10.1016/S0378-5173(01)00989-9 Drug delivery to the nail following topical application 

  48. Expert Opin. Drug Deliv. Murdan 5 11 1267 2008 10.1517/17425240802497218 Enhancing the nail permeability of topically applied drugs 

  49. Murthy 2012 Trans-Ungual Drug Delivery 

  50. Drug Dev. Ind. Pharm. Nair 37 1253 2011 10.3109/03639045.2011.568946 Transungual delivery of terbinafine by iontophoresis in onychomycotic nails 

  51. Eur. J. Pharm. Biopharm. Neves 69 622 2008 10.1016/j.ejpb.2007.12.007 Performance of an in vitro mucoadhesion testing method for vaginal semisolids: influence of different testing conditions and instrumental parameters 

  52. Drugs Niewerth 58 2 283 1999 10.2165/00003495-199958020-00005 Management of onychomycoses 

  53. Int. J. Pharm. Paavola 199 85 2000 10.1016/S0378-5173(00)00376-8 Controlled release injectable liposomal gel of ibuprofen for epidural analgesia 

  54. Crit. Rev. Ther. Drug Carrier Syst. Margalit 12 233 1995 10.1615/CritRevTherDrugCarrierSyst.v12.i2-3.30 Liposome-mediated drug targeting in topical and regional therapies 

  55. Int. J. Pharm. Repka 282 95 2004 10.1016/j.ijpharm.2004.06.010 Influence of human nail etching for the assessment of topical onychomycosis therapies 

  56. Arch. Pharm. Res. Rhee 29 12 1171 2006 10.1007/BF02969310 Effect of flavors on the viscosity and gelling point of aqueous poloxamer solution 

  57. Int. J. Pharm. Riley 217 87 2001 10.1016/S0378-5173(01)00592-0 An investigation of mucus/polymer rheological synergism using synthesised and characterised poly(acrylic acid)s 

  58. Br. J. Dermatol. Ryder 126 Suppl. 39 2 1992 10.1111/j.1365-2133.1992.tb00001.x Terbinafine: mode of action and properties of the squalene epoxidase inhibition 

  59. Br. J. Dermatol. Scher 130 Suppl. 43 15 1994 10.1111/j.1365-2133.1994.tb06087.x Onychomycosis is more than a cosmetic problem 

  60. Int. J. Adv. Pharm. Sivakranth 2 1 16 2012 Ethosomes: a novel vesicular drug delivery system 

  61. Int. J. Pharm. Sun 353 243 2008 10.1016/j.ijpharm.2007.11.017 Preparation and evaluation of N3-O-toluyl-fluorouracil-loaded liposomes 

  62. J. Controlled Release Touitou 65 40 2000 10.1016/S0168-3659(99)00222-9 Ethosomes novel vesicular carriers for enhanced delivery: characterization and skin penetration properties 

  63. Touitou, E., 1996. Composition of applying active substance to or through the skin. US patent, 5:716, 638. 

  64. Traynor vol. 11 90 2008 

  65. Int. J. Pharm. Trottaet 241 319 2002 10.1016/S0378-5173(02)00266-1 Elastic liposomes for skin delivery of dipotassium glycyrrhizinate 

  66. Eur. J. Pharm. Sci. Van Hoogdalem 5 119 1997 10.1016/S0928-0987(97)00270-4 Nail penetration of the antifungal agent oxiconazole after repeated topical application in healthy volunteers, and the effect of acetylcysteine 

  67. Int. J. Pharm. Vejnovic 386 185 2010 10.1016/j.ijpharm.2009.11.019 Investigation of different formulations for drug delivery through the nail plate 

  68. Int. J. Pharm. Vejnovic 397 67 2010 10.1016/j.ijpharm.2010.06.051 Permeation studies of novel terbinafine formulations containing hydrophobins through human nails in vitro 

  69. Int. J. Cosmet. Sci. Walters 5 231 1983 10.1111/j.1467-2494.1983.tb00348.x Permeability characteristics of the human nail plate 

  70. Biochim. Biophys. Acta Wessel 1433 210 1999 10.1016/S0167-4838(99)00129-6 Hydration of human nails investigated by NIR-FT-Raman spectroscopy 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로